Sentient Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Ebitda
- Net Worth
- Total Assets 225.54%
(FY 2020)
About Sentient Formulations
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raghunath Agarwal, Sharma Pulkit, Siddhant Pandey, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24290RJ2017PTC059589
- Company No.
059589
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sentient Formulations?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhimanyu Chundawat  | Director | 13-Aug-2018 | Current |
| Raghunath Agarwal | Additional Director | 28-Nov-2019 | Current |
| Sharma Pulkit | Director | 24-Nov-2017 | Current |
| Siddhant Pandey | Director | 24-Nov-2017 | Current |
| Jogendra Singh | Director | 13-Aug-2018 | Current |
| Narpat Singh | Additional Director | 13-Aug-2018 | Current |
Financial Performance of Sentient Formulations.
Sentient Formulations Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sentient Formulations?
Unlock access to Sentient Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Siddhi Vinayak Buildhome Limited Liabili Ty PartnershipActive 9 years 9 monthsRaghunath Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sentient Formulations?
Unlock and access historical data on people associated with Sentient Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sentient Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sentient Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
